Introduction
Gene ampli®cation is a mechanism utilized in tumor cells for increasing the expression of a protein whose activity promotes cell proliferation. The expression of several oncogene products have been shown to be elevated in tumors for which the corresponding gene is ampli®ed, and these include c-erbB2/neu in breast cancer and ovarian cancer (Slamon et al., 1989) , nmyc in neuroblastoma (Ramsay et al., 1986) , and epidermal growth factor receptor in glioblastoma (Wong et al., 1987) .
Several recent studies have demonstrated that regions of ampli®cation (amplicons) can be quite large and frequently contain multiple overexpressed sequences (Tanigami et al., 1992; Tomasetto et al., 1995; Bringuier et al., 1996; Reiter and Brodeur, 1996) . In most instances it is unclear whether the coampli®cation of multiple genes merely results from the proximity of`bystander' genes to a target sequence, or if it is indicative of a selection for the increased expression of sequences in addition to that of a presumed oncogene target. If selective pressure favors the overexpression of multiple genes, then one might suspect that the sequences involved could be independently ampli®ed. This possibility can be addressed by examining speci®c genomic regions for distinct and separate gene ampli®cations. For instance, it has been shown that the CDK4 and MDM2 genes which reside in 12q13-15 amplicons observed in sarcomas and malignant gliomas can be ampli®ed independently of one another (Berner et al., 1996; Reifenberger et al., 1996) . In combination with the information provided by investigations addressing the molecular biologic function of the cdk4 and mdm2 proteins, a compelling case can be presented for the combined tumor growth advantage that would be conferred by the coampli®cation of their respective loci.
As a result of the collective eort to characterize tumor amplicons, it is becoming increasingly apparent that a detailed knowledge of the genetic composition of these ampli®ed regions is necessary to better understand the contribution of ampli®cations to the biologic behavior of a cancer. To this purpose, we have used a battery of mapped expressed sequence tag (EST) probes to examine the EGFR region for novel gene ampli®cations in a series of primary glioblastomas as well as in two cell lines with ampli®ed EGFR. Our results indicate that this region does contain several expressed sequences that are ampli®ed and overexpressed.
Results
Thirteen EST probes were used for the Southern analysis of DNAs from 28 tumors and two cell lines with EGFR ampli®cation. The positional relationship between these expressed sequences has been presented in the framework of a genetic map shown in Figure 1 . All of the loci, as indicated by the Human Transcript (http://www.ncbi.nlm.nih.gov/SCIENCE96/) and Whitehead Institute Center for Genome Research (WICGR, http://www-genome.wi.mit.edu/) chromosome 7 maps, that reside in the same 2 cM interval as the EGFR gene were examined; the four remaining sequences reside in¯anking or overlapping regions.
Eleven of the 13 probes revealed their sequence ampli®cation in one or more of the samples tested (representative data shown in Figure 2 ; ampli®cation frequencies for the ESTs are listed in Table 1 ). The patterns of ampli®cation among the panel of tumor DNAs (Table 1) were unique to each EST, suggesting that each marker represents a distinct locus. Densitometric analysis of autoradiograms revealed signal intensity increases between six and 450x relative to normal tissue DNAs for ESTs showing ampli®cation (data not shown). In most instances, the level of ampli®cation was similar for all probes displaying ampli®cation in a given tumor DNA. The primary exception was for expressed sequence WI-14269 which showed decreased levels of ampli®cation relative to other ampli®ed sequences in four tumors.
Many of the markers that were tested have been placed on the WICGR radiation hybrid map and their map positions can be used to schematize the structure of the tumor amplicons ( Figure 3 ). This summary reveals 11 distinct amplicon types among the 28 tumors and two cell lines with EGFR ampli®cation, and suggests several instances of interrupted or discontinuous ampli®cation.
To determine whether any of the ESTs showed corresponding transcript overexpression in association with ampli®cation, Northern analysis was performed on RNAs from two cell lines with ampli®ed EGFR. Three of the 11 markers (SHGC11828, Cda1eb02 and Cda1bc08) showing ampli®cation in the tumors were determined to be ampli®ed and overexpressed in one or both cell lines, as compared with cell lines and normal control tissues without ampli®cation of this region (Southern and Northern results are shown in Figure 4) ; a distinct size was evident for each of the overexpressed transcripts. EST SGC32574, the only sequence that was co-ampli®ed with EGFR in all of the tumors (Table 1, Figure 3 ), was also ampli®ed in the cell lines with EGFR ampli®cation. However, Northern analysis revealed that no transcript was detected by the probe for this EST, either in the RNA from the cell lines for which it was ampli®ed or in RNAs from several normal tissues.
Discussion
In this study we have demonstrated that there are several expressed sequences that are frequently coampli®ed with EGFR. Our approach has involved the use of EST probes mapped to the EGFR region for Southern and Northern analysis, and has depended upon the existing density of the human transcript map (Schuler et al., 1996) . Our results demonstrate that this density is sucient to allow the identi®cation of novel sequences in close proximity to a well-characterized oncogene.
A unique aspect of EGFR ampli®cation concerns the size of the ampli®cation target which spans some 110 kb of genomic DNA (Haley et al., 1987) . Previous work directed at examining EGFR amplicons in squamous cell carcinoma cell lines through pulsed®eld gel electrophoresis indicated that the lengths of the ampli®ed regions were at least 500 kb (Kawasaki et al., 1988) . More recent work involving the analysis of MYCN and CDK4-MDM2 ampli®cations has revealed that tumor cell amplicons can substantially exceed this ®gure Reiter and Brodeur, 1996) . The average distance per centiRay on the WICGR radiation hybrid map has been estimated at 270 kb. Were this value accurate for the EGFR region, then the majority of the amplicons examined here (Figure 3 ) should be considerably larger than one megabase in size. In such an event, the amount of the genomic DNA ampli®ed would be several times more than that containing the EGFR gene and thereby contribute to a signi®cant probability of gene coampli®cation. The body of literature associated with amplicon characterizations has grown substantially during the past few years and in some instances this literature suggests that gene co-ampli®cations primarily result from the proximity of a locus relative to an actual ampli®cation target. For example, the DDX1 gene is often co-ampli®ed with MYCN in neuroblastoma, but has not been shown to be independently ampli®ed of MYCN (Manohar et al., 1995; George et al., 1996) . Consequently, the frequent co-ampli®cation of DDX1 with MYCN appears to be fortuitous, as may be the case for some or all of the ESTs investigated here. The inverse relationship between EST ampli®cation frequency and distance from the amplicon core, apparently marked by SGC32574, is consistent with this possibility (Table 1 and Figure 3 ).
An alternative explanation of these data is that there are multiple genes in EGFR amplicons whose overexpression are selected for during tumor development. Support for the existence of multiple ampli®cation targets in tumor amplicons comes from studies that have demonstrated the independent ampli®cation of loci that are frequently co-ampli®ed. In addition to the 12q13 ampli®cations of MDM2 and CDK4 in sarcomas and malignant gliomas (Berner et al., 1996; Reifenberger et al., 1996) , multiple distinct ampli®cations have been demonstrated for chromosomal locations 17q11-21 and 20q in breast cancer (Bieche et al., 1996; Tanner et al., 1996) .
At this stage it is unclear whether there are ampli®cation targets independent of EGFR in the chromosome 7p12 region; examination of a small number of tumors without EGFR ampli®cation has yet to reveal ampli®cation of any of the loci investigated here. However, the discontinuous nature of the ampli®cation units, as suggested by the data summary in Figure 3 , indicates the possibility of additional growth-advantageous genes in the region.
Sequence homology searches between ESTs and known genes can also provide information for speculation as to the importance of expressed sequence co-ampli®cation. For the three sequences that we have determined to be ampli®ed and overexpressed, only Cda1bc08 has an open reading frame of sucient length to provide meaningful results from a homology search. This expressed sequence displays signi®cant homology with the putative gene for 4-nitrophenylphosphatase of C. elegans (Wilson et al., 1994) . However, no relationship between the activity of such a protein and cell proliferation is readily apparent. Although these data suggest the identi®cation of 11 distinct, co-ampli®ed genes in EGFR amplicons (in addition to the patterns of ampli®cation shown in Table 1 , none of the indicated ESTs share a common Unigene (http://www.ncbi.nlm.nih.gov/Schuler/UniGene/designation), it is unlikely that the loci we have examined here will account for all or perhaps even the majority of expressed sequences contained in these amplicons. Work is in progress to identify and develop recombinant DNAs that will provide complete coverage of the ampli®ed regions. In addition to the physical map generated by this eort, these DNAs will serve as a resource for the further investigation of the genetic content of EGFR amplicons.
Materials and methods

Tumors and cell lines
All tumors examined were obtained from Mayo Clinic patients and were diagnosed as glioblastomas. Cell lines MDA468 and A431, both of which stably maintain ampli®ed EGFR (Merlino et al., 1984; Filmus et al., 1985) , and cell lines U138 and U87 were obtained from American Type Culture Collection.
EST selection and probe synthesis
ESTs (Table 1) were selected based upon their association with expressed sequences near or within the genetic region containing EGFR, as indicated by the Human Transcript Map database maintained by the National Center for Biotechnology Information (NCBI). Following amplification of ESTs, PCR samples were electrophoresed in 1.0% agarose gels, and fragments of appropriate size were excised and puri®ed using GeneClean II (Bio 101, Vista, CA). The insert from clone pE7 (obtained from ATCC) was used for the detection of EGFR sequences.
Nucleic acid extraction and analysis
Cell line and tumor DNAs were isolated as previously described (James et al., 1988) . DNAs were treated with restriction enzyme (EcoRI or HindIII), electrophoresed through 0.8% agarose, transferred to a reinforced nitrocellulose membrane (Nytran, Schleicher and Schuell), and ®xed to the membrane by baking in a vacuum oven at 808C for 2 h.
RNA extractions from cell lines were performed with a modi®cation of the technique described by Chomczynski and Sacchi (1987) in which pelleted cells were lysed in a guanidinium isothiocyanate-phenol solution (TRIZOL, GibcoBRL) by vortexing. After the solution of one ®fth volume of chloroform to sample lysates, specimens were vortexed again and centrifuged. Aqueous, RNA-containing phases were isolated from centrifuged specimens, and sample RNAs were precipitated with isopropanol and resuspended in DEPC-treated H 2 O. RNA samples were electrophoresed through formaldehyde-agarose gels (1.0%), and blot-transferred and ®xed to nitrocellulose membranes as described above. Normal tissue RNAs for human brain and placenta were obtained from Clontech (Palo Alto, CA).
DNA and RNA ®lters were hybridized with 32 P-labeled EST probes. After hybridization, ®lters were washed and exposed to X-ray ®lm; treatments of DNA and RNA ®lters for multiple, sequential hybridizations have been described previously (James et al., 1988; Ekstrand et al., 1991) .
Signal quantitation
Southern blot autoradiographic signal responses were quantitated by scanning X-ray ®lms with a BioRad (Richmond, CA) model 700 densitometer and analysing resulting images with the associated Molecular Analyst software. Signal responses resulting from hybridization and and one normal tissue control were examined for ampli®cation of EGFR and the expressed sequence loci indicated. The probes used in the Southern analysis were also used on Northern ®lters (right) to assess levels of expression for corresponding transcripts in the cell lines with EST ampli®cations as well as in two cell lines (U87 and U138) and normal tissues (NB=normal brain; PL=placenta) without ampli®cation of this region. Transcript sizes: EGFR=10.0 kb, SHGC11828=3.2 kb, Cda1eb02=4.4 kb, Cda1bc08=2.4 kb rehybridization of ®lters with EST probes were normalized and calculated as described previously (Ekstrand et al., 1991) .
